260441-44-9 Usage
General Description
2-(Piperidin-4-yl-oxy)-5-chloropyridine is a synthetic chemical compound that belongs to the category of organic compounds known as diarylethers. It is classified under pyridine and piperidine alkaloids. This specific compound has a piperidinyl group (a nitrogenous ring structure) combined with a chloropyridine moiety, which is a six-membered heterocyclic aromatic ring system that contains a chlorine atom. The ether linkage is characterized by an oxygen atom connecting the two ring systems. The properties and potential applications of this compound may depend on its reactivity with other substances, and it is relevant in chemical research. However, detailed research concerning its uses and effects is limited. Like other chemicals, careful handling, storage, and disposal are necessary.
Check Digit Verification of cas no
The CAS Registry Mumber 260441-44-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,0,4,4 and 1 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 260441-44:
(8*2)+(7*6)+(6*0)+(5*4)+(4*4)+(3*1)+(2*4)+(1*4)=109
109 % 10 = 9
So 260441-44-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H13ClN2O/c11-8-1-2-10(13-7-8)14-9-3-5-12-6-4-9/h1-2,7,9,12H,3-6H2
260441-44-9Relevant articles and documents
NOVEL CRYSTAL MODIFICATIONS
-
Page/Page column 47, (2008/06/13)
Novel crystal modifications of (5S)-5-[4-(5-chloro-pyridin-2-yloxy)-piperidine-1-sulfonylmethyl]-5-methyl-imidazolidine-2,4-dione are disclosed together with processes for preparing such modifications, pharmaceutical compositions comprising such a modification, and the use of such a modification in therapy.
NOVEL AZA-RING DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
-
Page 16-18, (2008/06/13)
This invention relates to novel aza-dng dedvatives useful as monoamine neurotransmifter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
Compounds
-
, (2008/06/13)
Compounds of the formula I useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.